---
title: Research
author: ""
categories: []
tags: []
description: ""
images:
- '/img/research_figs/LasseigneLabOverview_2023.png'
linktitle: ""
---
_<p style="text-align:center;">The Lasseigne Lab develops and applies genomic strategies to map molecular processes contributing to the etiology, progression, and treatment of diseases originating in the brain and/or the kidney. We investigate the impact of cell- and tissue-specific gene and transcript regulation and expression, cell-cell communication, and sex-associated molecular changes on disease manifestation. Through computational machine learning and data-driven approaches, we identify optimal precision preclinical models and nominate and prioritize drug targets and repositioning candidates for treating patient cellular phenotypes.</p>_

---
___________________________________________________________________________________________
# <ins><p style="text-align:center;" id="current">Kidney Research</p></ins>

<img src="/img/research_figs/PKDOverview2023.png" alt="">

__<a href="https://molmed.biomedcentral.com/articles/10.1186/s10020-023-00664-z" target="_blank">Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion, Molecular Medicine, 2023.</a>__
___________________________________________________________________________________________

# <ins><p style="text-align:center;" id="current">Brain Research</p></ins>

<img src="/img/research_figs/PKDOverview2023.png" alt="">

__<a href="https://molmed.biomedcentral.com/articles/10.1186/s10020-023-00664-z" target="_blank">Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion, Molecular Medicine, 2023.</a>__
___________________________________________________________________________________________

# <ins><p style="text-align:center;" id="current">Drug Target and Repurposing Prioritization</p></ins>

<img src="/img/research_figs/PKDOverview2023.png" alt="">

__<a href="https://molmed.biomedcentral.com/articles/10.1186/s10020-023-00664-z" target="_blank">Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion, Molecular Medicine, 2023.</a>__
___________________________________________________________________________________________

# <ins><p style="text-align:center;" id="current">Cross-Species Analyses</p></ins>

<img src="/img/research_figs/PKDOverview2023.png" alt="">

__<a href="https://molmed.biomedcentral.com/articles/10.1186/s10020-023-00664-z" target="_blank">Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion, Molecular Medicine, 2023.</a>__
___________________________________________________________________________________________

<div class="card">
    <a href="/projects/multiomics" title="" class="card-image hover-overlay">
      <p style="text-align:center;"><img src="/img/research_figs/multiomicsfig.png" alt="" class="img-responsive" width="500"></p>
    </a>
    <div class="card-text">
     <h4><p style="text-align:center;"><a href="/projects/multiomics">MULTIOMICS ASSAY AND ANALYTICAL APPROACHES</a></p></h4>
       <div class="card-desription">
      <p style="text-align:center;">Discovery of cancer (e.g., kidney, GBM, prostate, etc.) diagnostic biomarkers and therapeutic signatures</p>
    </div>
  </div>

_<p style="text-align:center;">Learn more about our ongoing projects in Polycystic Kidney Disease:</p>_
